References
- International Conference on Harmonisation. (1997). Testing for Carcinogenicity of Pharmaceuticals.
- Morton D, Alden CL, Roth AJ, Usui T. (2002). The Tg rasH2 mouse in cancer hazard identification. Toxicol Pathol 30:139–146.
- Neugebauer G, Akpan W, von Möllendorff E, Neubert P, Reiff K. (1987). Pharmacokinetics and disposition of carvedilol in humans. J Cardiovasc Pharmacol 10 Suppl 11:S85–S88.
- Rasmussen K, Booth GM, Lee M L,Castle, RN. (1991). Mutagenicities of hydroxy-substituted carbazoles and dibenzothiophenes using the CHO/HGPRT assay. Environ Toxicol Chem 10:1133–1137.
- Ring B J, Wrighton SA. (2000). Industrial viewpoint: Application of in vitro drug metabolism in various phases of drug development. In Metabolic Drug Interactions (Levy RH, Thummel KE, Trager WF, Hansten PD, Eichelbaum M, editors) pp 29–40, Philadelphia, Lippincott Williams and Wilkins.
- Schaefer WH, Politowski J, Hwang B, Dixon F Jr, Goalwin A, Gutzait L, Anderson K, DeBrosse C, Bean M, Rhodes GR. (1998). Metabolism of carvedilol in dogs, rats, and mice. Drug Metab Dispos 26:958–969.
- Szafarz D, Périn F, Valéro D, Zajdela F. (1988). Structure and carcinogenicity of dibenzo(c,g)carbazole derivatives. Biosci Rep 8:633–643.
- Takaoka M, Sehata S, Maejima T, Imai T, Torii M, Satoh H, Toyosawa K, Tanakamaru ZY, Adachi T, Hisada S, Ueda M, Ogasawara H, Matsumoto M, Kobayashi K, Mutai M, Usui T. (2003). Interlaboratory comparison of short-term carcinogenicity studies using CB6F1-rasH2 transgenic mice. Toxicol Pathol 31:191–199.
- Thomas DG, Breslow N, Gart JJ. (1977). Trend and homogeneity analyses of proportions and life table data. Comput Biomed Res 10:373–381.
- Tsuda H, Hagiwara A, Shibata M, Ohshima M, Ito N. (1982). Carcinogenic effect of carbazole in the liver of (C57BL/6N x C3H/HeN)F1 mice. J Natl Cancer Inst 69:1383–1389.
- VandenBranden M, Wrighton SA, Ekins S, Gillespie JS, Binkley SN, Ring BJ, Gadberry MG, Mullins DC, Strom SC, Jensen CB. (1998). Alterations of the catalytic activities of drug-metabolizing enzymes in cultures of human liver slices. Drug Metab Dispos 26:1063–1068.
- Xue W, Siner A, Rance M, Jayasimhulu K, Talaska G, Warshawsky D. (2002). A metabolic activation mechanism of 7H-dibenzo[c,g]carbazole via o-quinone. Part 2: Covalent adducts of 7H-dibenzo[c,g]carbazole-3,4-dione with nucleic acid bases and nucleosides. Chem Res Toxicol 15:915–921.